Physician profile
Bernardo Flasterstein
NPI 1649325051
$12,807.88
in general payments reported to CMS, 2019-2025
27 companies · $618 in 2025
The $618 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $24.09 · 2021: $153 · 2022: $512 · 2023: $578 · 2024: $529 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,724.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $8,701.96 | 2019-2024 | |
| Livanova USA, INC. | $1,429.50 | 2019 | |
| Ucb, INC. | $1,265.18 | 2021-2025 | Fintepla, Briviact |
| Supernus Pharmaceuticals, INC. | $201.65 | 2023-2025 | Qelbree, Qelbree |
| Neurelis, INC. | $186.41 | 2022-2023 | Valtoco |
| Greenwich Biosciences, INC. | $163.31 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $148.53 | 2023-2025 | Daybue |
| Genentech USA, INC. | $133.42 | 2024 | Evrysdi |
| Sk Life Science, INC. | $126.99 | 2021-2023 | |
| Eisai INC. | $122.17 | 2019 | |
| Jazz Pharmaceuticals INC. | $79.45 | 2022-2024 | |
| Harmony Biosciences LLC | $49.69 | 2025 | |
| Biomarin Pharmaceutical INC. | $34.80 | 2024 | Brineura |
| Biocodex, INC. | $25.65 | 2023 | Diacomit |
| Aquestive Therapeutics, INC. | $25.53 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Springworks Therapeutics, INC. | $24.54 | 2025 | |
| Corium, LLC | $24.21 | 2022 | |
| Tris Pharma INC | $22.96 | 2025 | Onyda Xr |
| Catalyst Pharmaceuticals, INC. | $21.54 | 2023 | Fycompa |
| Novartis Pharmaceuticals Corporation | $20.39 | 2019 |
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernardo Flasterstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.